Search

everythinglearnresearchcommunity

for

Search:↓

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Every elderly patient had at least one skin condition, often linked to other diseases, highlighting the need for integrated skin and general healthcare in the elderly.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Mutations in certain receptors can cause diseases and offer new treatment options.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Trichoscopy helps tell apart scalp lesions in pemphigus vulgaris and pemphigus foliaceus and is useful for choosing biopsy locations.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Testicular microlithiasis may increase the risk of testicular cancer and patients with it should be closely monitored.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

Juniperus plants contain compounds with potential for developing various medical treatments.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.